WP
Woodline Partners Portfolio holdings
AUM
$18.9B
1-Year Return
23.37%
This Quarter Return
+12.81%
1 Year Return
+23.37%
3 Year Return
+125.78%
5 Year Return
+185.63%
10 Year Return
–
AUM
$18.9B
AUM Growth
+$3.55B
(+23%)
Cap. Flow
+$2.5B
Cap. Flow
% of AUM
13.19%
Top 10 Holdings %
Top 10 Hldgs %
14.56%
Holding
1,090
New
199
Increased
468
Reduced
192
Closed
179
Top Buys
| 1 |
Microsoft
MSFT
|
+$247M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
+$152M |
| 3 |
Brown & Brown
BRO
|
+$120M |
| 4 |
Arthur J. Gallagher & Co
AJG
|
+$113M |
| 5 |
Akero Therapeutics
AKRO
|
+$106M |
Top Sells
| 1 |
Lam Research
LRCX
|
+$144M |
| 2 |
MetLife
MET
|
+$97.2M |
| 3 |
Travelers Companies
TRV
|
+$91.9M |
| 4 |
Electronic Arts
EA
|
+$91.9M |
| 5 |
SWTX
SpringWorks Therapeutics
SWTX
|
+$80.3M |
Sector Composition
| 1 | Healthcare | 25.08% |
| 2 | Technology | 24.07% |
| 3 | Financials | 10.59% |
| 4 | Consumer Discretionary | 9.42% |
| 5 | Industrials | 7.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ETOR
701
eToro Group Ltd. Class A Common Shares
ETOR
$3.85B
| $2.33M | 0.01% |
+35,000
| New | +$2.33M |
|
702
Taysha Gene Therapies
TSHA
$917M
| $2.31M | 0.01% |
1,000,254
+142,000
| +17% | +$328K |
|
703
T Rowe Price
TROW
$23.8B
| $2.3M | 0.01% |
23,832
+5,023
| +27% | +$485K |
|
704
Regions Financial
RF
$24.1B
| $2.29M | 0.01% |
97,236
+20,439
| +27% | +$481K |
|
705
NXP Semiconductors
NXPI
$56.9B
| $2.28M | 0.01% |
+10,453
| New | +$2.28M |
|
706
ADC Therapeutics
ADCT
$396M
| $2.26M | 0.01% |
842,900
+27,369
| +3% | +$73.3K |
|
707
CMS Energy
CMS
$21.2B
| $2.24M | 0.01% |
32,356
+7,113
| +28% | +$493K |
|
708
FirstEnergy
FE
$25B
| $2.24M | 0.01% |
55,568
+12,234
| +28% | +$493K |
|
709
Williams-Sonoma
WSM
$24.8B
| $2.17M | 0.01% |
13,299
+2,899
| +28% | +$474K |
|
710
Intapp
INTA
$3.67B
| $2.16M | 0.01% |
41,819
-101,215
| -71% | -$5.22M |
|
711
Texas Pacific Land
TPL
$21B
| $2.15M | 0.01% |
2,039
+447
| +28% | +$472K |
|
712
Edison International
EIX
$20.5B
| $2.15M | 0.01% |
41,620
+8,911
| +27% | +$460K |
|
|
INZY
713
DELISTED
Inozyme Pharma
INZY
| $2.14M | 0.01% |
535,185
-468,554
| -47% | -$1.87M |
|
714
Sana Biotechnology
SANA
$762M
| $2.13M | 0.01% |
781,222
+566
| +0.1% | +$1.55K |
|
715
Dollar Tree
DLTR
$20.3B
| $2.12M | 0.01% |
21,368
+4,290
| +25% | +$425K |
|
716
Global Payments
GPN
$21.2B
| $2.11M | 0.01% |
26,380
-173,113
| -87% | -$13.9M |
|
|
RAPP
717
Rapport Therapeutics
RAPP
$1.15B
| $2.1M | 0.01% |
185,028
+3,000
| +2% | +$34.1K |
|
718
Citizens Financial Group
CFG
$22.3B
| $2.1M | 0.01% |
46,908
+9,976
| +27% | +$446K |
|
719
Norfolk Southern
NSC
$61.8B
| $2.08M | 0.01% |
8,133
+7,286
| +860% | +$1.86M |
|
720
McCormick & Company Non-Voting
MKC
$18.8B
| $2.07M | 0.01% |
27,332
+5,998
| +28% | +$455K |
|
|
HNGE
721
Hinge Health, Inc.
HNGE
$4.47B
| $2.07M | 0.01% |
+40,000
| New | +$2.07M |
|
722
NiSource
NI
$18.9B
| $2.05M | 0.01% |
50,915
+11,212
| +28% | +$452K |
|
723
ArcelorMittal
MT
$26B
| $2.04M | 0.01% |
+64,672
| New | +$2.04M |
|
724
Perrigo
PRGO
$3.12B
| $2.03M | 0.01% |
75,819
| – | – |
|
725
Tapestry
TPR
$21.8B
| $1.97M | 0.01% |
22,438
+4,948
| +28% | +$434K |
|